Organigram’s growth is nothing to weed out, says Haywood Capital Markets’s analyst Neal Gilmer, who’s holding firm on his ...

Despite near-term headwinds, Goff said recent quarterly trends and the outlook for the second half of the year remain ...

Telus Digital Experience is showing early signs of a turnaround, prompting National Bank of Canada Financial’s Richard Tse to ...

In a May 11 research note, Rosenberg said VitalHub is showing strong organic growth through its patient flow software ...

Analyst Suji Desilva of Roth Capital maintained a Buy rating on D-Wave Quantum and raised the 12-month price target from $10 ...

Concerns over U.S. tariff policy changes drove a sharp pullback in Shopify stock earlier in the year. However, Toner noted ...

The announcement prompted ATB Capital Markets analyst Martin Toner to downgrade Docebo from “Outperform” to “Sector Perform” ...

Following the company’s most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about ...

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Roth Capital Partners has raised its price target on Groupon ( Groupon Inc Stock Quote, Chart, News, Analysts, Financials ...